Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Partnership with Equens

4 Jun 2013 07:00

RNS Number : 1918G
Vipera PLC
04 June 2013
 



 

 

For immediate release 4 June 2013

 

Vipera - Equens partnership

 

Vipera, the specialist provider of mobile financial services, today announces that Equens (www.equens.com ), the largest pan-European payment processor, and who leads the market for future-proof payments and card processing solutions, has recently started to offer Motif, the Vipera product, to its customers. This follows an in depth evaluation conducted together with one of their German bank customers, who has now progressed to conducting a trial implementation of Motif. 

 

Commenting on partnership, Vipera Chief Executive Officer Marco Casartelli said:

"This new partnership reinforces Vipera's position as a growing provider of mobile financial services. The strategic endorsement by a European brand leader in payment processing comes at an exciting time. Like Vipera, Equens is working with leading players to ensure that future mobile payment technologies are as easy, simple and secure as card-based transactions are today."

 

"Providing a trusted platform to allow banking and payments via mobile is key to Vipera aspirations and we are delighted by the role we are playing in making that happen. Financial institutions demand resilient and robust infrastructure and Vipera's credentials in this arena are now starting to give it increased traction in many business segments."

 

 -Ends-

 Vipera PLC

Marco Casartelli

Tel: +39 02 863 371

Martin Perrin

Tel: +44 (0) 7785 505 337

Beaumont Cornish Limited (Nomad)

Tel: +44 (0) 20 7628 3396

Roland Cornish

Felicity Geidt

 

 

Notes to Editors

 

Equens SE is one of the largest payment processors in Europe, leading the market for future-proof payment and card solutions. With clients and partnerships in multiple European countries, the company offers pan-European market coverage from offices in four countries - the Netherlands, Germany, Italy and Finland. And with an annual processing volume of 9.7 billion payments and 3.9 billion POS and ATM transactions, Equens SE has a European market share of more than 12.5%.

 

Vipera provides software and services to banks and financial institutions, primarily through its Motif platform, to enable mobile access to personal financial services. Additionally Vipera's software enables Government and corporate entities to allow their services and consumer transactions to take place on mobile platforms. All products within the Motif suite share market leading security models, a consumer friendly interface and support for different devices and languages.

 

Vipera's partnership with Equens, provides an extensive set of mobile financial services, from cross-bank mobile banking to money transfer and real time financial transaction alerting. Vipera has also integrated additional functionalities such as airtime top-up, QR-code and NFC payment, couponing and loyalty schemes.

 

Vipera's headquarters are in Milan and it listed on the London Stock Exchange (AIM: VIP.L). For further information, please visit www.vipera.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSUFWDFDSESM
Date   Source Headline
20th Dec 20247:00 amRNSTransaction in Own Shares
26th Nov 202411:29 amRNSHalf-year Report - Replacement
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20245:14 pmRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20245:19 pmRNSTransaction in Own Shares
18th Nov 20244:57 pmRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20245:05 pmRNSTransaction in Own Shares
12th Nov 20245:49 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20245:13 pmRNSTransaction in Own Shares
15th Oct 20245:21 pmRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20244:55 pmRNSTransaction in Own Shares
7th Oct 20245:18 pmRNSTransaction in Own Shares
3rd Oct 202410:31 amRNSStatement re MAR
3rd Oct 202410:08 amRNSPortfolio Update and Half Year End Valuation
18th Sep 20249:38 amRNSDividend Declaration
9th Sep 20247:00 amRNSChange of AIFM
23rd Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 20243:22 pmRNSDirectorate Change
11th Jul 20241:13 pmRNSResult of AGM
20th Jun 20245:37 pmRNSTransaction in Own Shares
12th Jun 20247:00 amRNSAnnual Financial Report
29th Apr 20244:58 pmRNSTransaction in Own Shares
25th Apr 20245:01 pmRNSTransaction in Own Shares
24th Apr 20245:24 pmRNSTransaction in Own Shares - Replacement
24th Apr 20245:11 pmRNSTransaction in Own Shares
23rd Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 20244:56 pmRNSTransaction in Own Shares
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20245:13 pmRNSTransaction in Own Shares
4th Apr 20244:59 pmRNSTransaction in Own Shares
4th Apr 202411:39 amRNSStatement re MAR
2nd Apr 20247:00 amRNSAcquisitions and Year End Portfolio Valuation
19th Mar 20245:01 pmRNSTransaction in Own Shares
18th Mar 20244:49 pmRNSTransaction in Own Shares
14th Mar 20244:54 pmRNSTransaction in Own Shares
11th Mar 20245:06 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:49 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDividend Declaration
6th Feb 20245:01 pmRNSTransaction in Own Shares
22nd Dec 202312:26 pmRNSHolding(s) in Company
21st Dec 20234:30 pmRNSDirector/PDMR Shareholding
20th Dec 202311:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.